Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia

Sinus Bradycardia Clinical Trial

Official title:
A Multicenter Randomized Controlled Study of Cardiac Autonomic Nerve Improvement and Pacemaker Therapy in Patients With Sinus Bradycardia

Status Not yet recruiting

Clinical Trial Summary

This is a multicenter randomized controlled study. By comparing patients with sinus bradycardia undergoing cardiac autonomic ganglion ablation and pacemaker therapy, and long-term follow-up to evaluate its safety and effectiveness after surgery, in order to evaluate the safety and effectiveness of cardiac autonomic ganglion ablation in the treatment of sinus bradycardia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05021627
Study type	Interventional
Source	Shanghai Chest Hospital
Contact	Xu Liu, MD
Phone	+8613052320103
Email	heartlx@sina.com
Status	Not yet recruiting
Phase	N/A
Start date	September 1, 2021
Completion date	August 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06276816` - Cardiac Denervation Ablation Strategy for Severe Sinus Bradycardia
Enrolling by invitation	`NCT05903313` - A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software
Completed	`NCT02462941` - Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart	Phase 1
Active, not recruiting	`NCT01200667` - uPHI: Wireless Body Area Network Core Technology	N/A
Completed	`NCT02400983` - Real Life Automatic Atrial Capture Device Control	N/A
Completed	`NCT00832260` - IES-ACap: Influence of Atrial Pulse Width in the Behaviour of ACap™ Confirm Algorithm.